REFERENCES

• National Cancer Institute. Dictionary of Cancer Terms. http://www.nci.nih.gov (accessed Nov 2006)
• Ferlay J et al, editors. Globocan 2000: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No.5. Version 1.0. IARC Press, 2001. Lyon, France.
• Barrasso R, Guillemotonia A. Cervix and vagina: Diagnosis. In: Gross, Barrasso Eds. Human papillomavirus infection: A clinical atlas. Ullstein Mosby, 1997. P147–274.
• Walboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19.
• Munoz N. Human papillomavirus and cancer: The epidemiological evidence.J Clin Virol 2000; 19:1-5.
• Pagliusi SR and Aguado MT. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine 2004; 23:569-578.
• Centres for Disease Control and Prevention. Genital HPV infection fact sheet. http://www.cdc.gov/std/hpv/stdfact-hpv.html. (accessed July 2006).
• IARC Handbooks of Cancer Prevention. IARC Press; 2005. Chapter 4: Efficacy of screening. P163-199.
• Cancer BackUp.  (accessed November 2006)
• Cancer Research UK, Cancer Incidence Stats 2002 (accessed Nov 2006)
• Cancer Research UK, Cancer Mortality Figures 2004
• Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
• Koutsky LA, Galloway DA and Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10:122-163
• Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32(Suppl 1): S59-66.
• Bosch FX and de Sanjosé S. Chapter 1: Human papillomavirus and cervical cancer – Burden and Assessment of causality. J Natl Cancer Inst Monogr 2003; 31:3-13.
• Schiffman M and Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; 31:14–19.
• Sherman ME, Lorincz AT, Scott DR et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis. J Natl Cancer Inst  2003; 95:46– 52
• Health Protection Agency CDR Weekly 2001; 11(35)
• NHS Cancer Screening Program. Cervical Screening - A Pocket Guide. Cervical Screening Pocket Guide 2005; 1: 258
• Cancer BackUp, Stages and Grading (accessed November 2006)
• Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 2005; 32S:S1-6.
• Munoz N, Bosch FX, Castellsague X et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:278-285
• Clifford GM, Smith JS, Plummer M et al. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 2003; 88:63-73.
• Clifford GM, Smith JS, Aguado T et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis.  Br J Cancer 2003; 89:101-105.
• Clifford GM, Rana RK, Franceschi S et al. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer.  Cancer Epidemiol Biomarkers Prev 2005; 14:1157-1164.
• Von Krogh G. Management of anogenital warts (condylomata acuminata). Eur J Dermatol 2001; 11:598-604.
• Winer RL, Lee S-K, Hughes JP et al. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-226.
• Sonnex C, Strauss S and Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Inf 1999; 75:317-319.
• Herrero R, Castellsague X, Pawlita M et al. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicentre study. J Natl Cancer Inst 2003; 95:1772-1783.
• NHS Cancer Screening Programmes. Cervical Screening - A pocket guide. 2004
• NHS. Scotland Cervical screening programme. http://www.nsd.scot.nhs.uk/services/cervical/ 2006 (accessed Nov 2006)
• Cervical Screening Wales. Cervical Screening the facts. (accessed Nov 2006)
• Sawaya GF, McConnell KJ, Kulsingam SL et al. Risk of cervical cancer associated with extending the interval between cervical cancer screenings. N Engl J Med 2003; 349:1501-1509.
• Beutner KR and Wiley DJ. Recurrent external genital warts: A literature review. Papillomavirus Rep 1997; 8:69-74.
• Clinical Effectiveness Group (Association for Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National guideline for the management of anogenital warts.
• Madeleine MM, Daling JR, Carter JJ et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997; 89:1516-1523.
• Daling JR, Madeleine MM, Schwartz SM et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002; 84:263-270.
• Esiashvili N, Landry J and Matthews RH. Carcinoma of the anus: Strategies in management. The Oncologist 2002; 7:188-199.
• Kosko JR and Derkay CS. Role of cesarean section in prevention of recurrent respiratory papillomatosis – Is there one? Int J Pediatr Otorhinolaryngol 1996; 35:31-38.
• Silverberg MJ, Thorsen P, Lindeberg H et al. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg 2004;130:711-716.
• McMillan A. The management of difficult anogenital warts. Sex Transm Inf 1999;75:192–194.
• Health Protection Agency 2005. (accessed Nov 2006)
• Quinn M, Babb P, Jones J et al. Effect of screening on incidence and mortality from cancer and cervix in England: Evaluation based on routinely collected statistics. BMJ 1999; 318: 904-908
• Collins S, Mazloomzadeh S, Winter H et al. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. BJOG 2002; 109:96-98.
• Ferlay J et al, editors. Globocan 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No.5. Version 2.0. IARC Press, 2004. Lyon, France.
• Maw RD, Reitano M and Roy M. An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998; 9:571-578.
• Kjaer SK, Chackerian B, van den Brule AJC et al. High-risk human papillomavirus is sexually transmitted: Evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001; 10:101-106.